COPD Management: We Can Do Better

March 21, 2023
Table of Contents

Taking a "whole person" approach to healthcare means addressing limitations that prevent individuals from getting the most effective care possible. Gaps in care can significantly impact a person's quality of life, the efficacy of provider-prescribed treatments, and have lasting financial implications. 

This article examines the gaps in COPD care, demonstrates the importance of accounting for COPD in your roadmap, and discusses how Wellinks is addressing clinical needs for better patient outcomes and long-term cost savings.

Lived Patient Experience

When managed properly, it is possible to maintain a good quality of life while living with COPD. However, barriers exist to accessing effective care and treatment options, preventing a majority of the 16.4 million Americans* living with the disease from maintaining their well-being. 

Wellinks, in collaboration with the COPD Foundation, conducted a survey to better understand the perspectives and experiences of people living with COPD in the United States. What we discovered was shocking. 

  • Many of the respondents required emergency medical intervention, unplanned hospital visits, and the use of oral steroids or antibiotics to combat COPD-related exacerbations
  • 25% of those who had been admitted to the hospital needed to be readmitted again within 30 days

Go Deeper: The Lived Experiences of People with COPD

Not only do these emergency visits and additional treatments negatively impact a person's physical and mental well-being, but they also rack up staggering medical debt. On average, individuals with COPD accumulate $6,246* more per year in medical costs than someone without COPD. The startling statistics bring to mind many questions, with the most critical being: 

  • Why did respondents continue to need emergency care? 
  • Where are the gaps between care plans and patient needs?
  • What can be done to reduce or prevent COPD-related hospitalizations?

Lack of Access to Effective Care, Especially Pulmonary Rehabilitation

One of the most recommended and effective treatment options for people with COPD is Pulmonary rehabilitation (PR). Shockingly, less than 3%* of that population utilizes this therapy due to significant barriers and gaps.

From the provider side: 

  • They are unable to prescribe treatment, as there is an estimated 18,000 COPD patients* for every 1 PR facility (pre-COVID count)
  • PR facilities are regularly overcapacity and unable to take new patients 
  • Issues with reimbursement in comparison to other clinics (i.e., cardiac rehab, physical therapy), which proliferates shortages

From the individual's standpoint:

  • Breathlessness, low oxygen levels, mobility, and transportation challenges prevent individuals with COPD from leaving their homes
  • Patients are also only allotted so many visits by their health plans to limit the cost of this service, as providers get reimbursed per session

A solution can be found in the large appetite that exists for more accessible, integrated, and virtual care options that meet people where they are. Virtual tools are essential as they can simplify the patient experience and overcome physical barriers limiting access to care. Our survey identified strong demand, and people with COPD are ready for change. 

Wellinks integrated, virtual-first COPD management solution is resolving these gaps in care by increasing access to high-quality care outside of the doctor's office. Our connected devices give members the following:

  • Access to virtual PR with tailored exercises, motivational support, and the education needed to better self-manage symptoms
  • The ability to track their health data and make adjustments to meet goals, prevent exacerbations, and avoid unnecessary emergency room visits
  • A dedicated care team that shares educational resources and provides ongoing support

Virtual solutions help individuals overcome the mental and physical barriers associated with COPD. Wellinks is actively addressing the gaps and barriers preventing individuals with COPD from obtaining better health and providers from offering critical support. Our approach has demonstrated increased levels of self-efficacy among members and has seen significant improvements in their quality of life. 

Go Deeper: Member Testimonial: Meet Phyliss 

Financial Impact & Solutions

From a financial standpoint, the need to address these gaps are critical. COPD is the 5th most costly chronic disease in the U.S. and has $49B in associated healthcare costs that are expected to grow to $800B in the next 20 years due to:

  • Aging populations, proliferating respiratory diseases
  • Increasing levels of comorbidities (diabetes, hypertension, heart disease, etc.)
  • Worsening environmental conditions
  • Continued tobacco use

Moreover, a large portion of these costs can be attributed to in-patient management of exacerbations, including preventable ED visits and hospitalizations. 

The financial burden COPD places on our healthcare industry can be reduced or avoided by educating patients on how to manage their COPD properly. Wellinks takes a proactive, whole-person approach to COPD care to improve patient outcomes and reduce medical expenses.

  • 50% decrease in in-patient treatments
  • 40% decrease in emergency department visits
  • 15% decrease in other related medical expenses

Go Deeper: Show me the Numbers 

This approach is representative of the Value-Based Care (VBC) model and has the possibility to impact other diseases, thus lowering overall healthcare costs. While slowly being adopted across the healthcare industry, this model can significantly impact a disease like COPD as it is a progressive, non-curable disease with a history that demonstrates exacerbations create long-term deficits to a patient's health. Preventative care and avoiding exacerbations are techniques for managing this condition. However, it is essential to encourage self-efficacy and self-management for better patient results. PR is a vital piece in the puzzle for preventing the downward progression of those living with COPD, and the VBC model allows for more innovative approaches to disease management.

Go Deeper: AHIP Webinar 

Working Towards Change

It is clear that the current system for COPD care is not working. 

Individuals are not getting the care they need to manage their condition, and healthcare providers are overwhelmed and unable to meet the demand. The current approach to care is reactive, increasing costs on the individuals, providers, and payors. It's time for a change; "whole-person" care starts at the top. For patients, it's their quality of life which includes physical, mental, emotional, and financial health. For providers, it's their treatment plans' effectiveness and ability to give critical care where it's needed. For payors, it is the need to reduce costs wherever and whenever possible.

Wellinks is working to address significant gaps in COPD care. Contact us to learn how we can help improve outcomes and lower costs. 

Subscribe to our newsletter and follow us on social media to stay up to date on the latest industry news and updates.

*SOURCES:

American Lung Association - COPD Trends Brief: Prevalence 

National Library of Medicine - COPD Affects Worker Productivity and Health Care Costs

National Library of Medicine - The Need For Expanding Pulmonary Rehabilitation Services 

JAMA Network - Cost-Effectiveness of Pulmonary Rehabilitation Among US Adults with COPD

Taking a "whole person" approach to healthcare means addressing limitations that prevent individuals from getting the most effective care possible. Gaps in care can significantly impact a person's quality of life, the efficacy of provider-prescribed treatments, and have lasting financial implications. 

This article examines the gaps in COPD care, demonstrates the importance of accounting for COPD in your roadmap, and discusses how Wellinks is addressing clinical needs for better patient outcomes and long-term cost savings.

Lived Patient Experience

When managed properly, it is possible to maintain a good quality of life while living with COPD. However, barriers exist to accessing effective care and treatment options, preventing a majority of the 16.4 million Americans* living with the disease from maintaining their well-being. 

Wellinks, in collaboration with the COPD Foundation, conducted a survey to better understand the perspectives and experiences of people living with COPD in the United States. What we discovered was shocking. 

  • Many of the respondents required emergency medical intervention, unplanned hospital visits, and the use of oral steroids or antibiotics to combat COPD-related exacerbations
  • 25% of those who had been admitted to the hospital needed to be readmitted again within 30 days

Go Deeper: The Lived Experiences of People with COPD

Not only do these emergency visits and additional treatments negatively impact a person's physical and mental well-being, but they also rack up staggering medical debt. On average, individuals with COPD accumulate $6,246* more per year in medical costs than someone without COPD. The startling statistics bring to mind many questions, with the most critical being: 

  • Why did respondents continue to need emergency care? 
  • Where are the gaps between care plans and patient needs?
  • What can be done to reduce or prevent COPD-related hospitalizations?

Lack of Access to Effective Care, Especially Pulmonary Rehabilitation

One of the most recommended and effective treatment options for people with COPD is Pulmonary rehabilitation (PR). Shockingly, less than 3%* of that population utilizes this therapy due to significant barriers and gaps.

From the provider side: 

  • They are unable to prescribe treatment, as there is an estimated 18,000 COPD patients* for every 1 PR facility (pre-COVID count)
  • PR facilities are regularly overcapacity and unable to take new patients 
  • Issues with reimbursement in comparison to other clinics (i.e., cardiac rehab, physical therapy), which proliferates shortages

From the individual's standpoint:

  • Breathlessness, low oxygen levels, mobility, and transportation challenges prevent individuals with COPD from leaving their homes
  • Patients are also only allotted so many visits by their health plans to limit the cost of this service, as providers get reimbursed per session

A solution can be found in the large appetite that exists for more accessible, integrated, and virtual care options that meet people where they are. Virtual tools are essential as they can simplify the patient experience and overcome physical barriers limiting access to care. Our survey identified strong demand, and people with COPD are ready for change. 

Wellinks integrated, virtual-first COPD management solution is resolving these gaps in care by increasing access to high-quality care outside of the doctor's office. Our connected devices give members the following:

  • Access to virtual PR with tailored exercises, motivational support, and the education needed to better self-manage symptoms
  • The ability to track their health data and make adjustments to meet goals, prevent exacerbations, and avoid unnecessary emergency room visits
  • A dedicated care team that shares educational resources and provides ongoing support

Virtual solutions help individuals overcome the mental and physical barriers associated with COPD. Wellinks is actively addressing the gaps and barriers preventing individuals with COPD from obtaining better health and providers from offering critical support. Our approach has demonstrated increased levels of self-efficacy among members and has seen significant improvements in their quality of life. 

Go Deeper: Member Testimonial: Meet Phyliss 

Financial Impact & Solutions

From a financial standpoint, the need to address these gaps are critical. COPD is the 5th most costly chronic disease in the U.S. and has $49B in associated healthcare costs that are expected to grow to $800B in the next 20 years due to:

  • Aging populations, proliferating respiratory diseases
  • Increasing levels of comorbidities (diabetes, hypertension, heart disease, etc.)
  • Worsening environmental conditions
  • Continued tobacco use

Moreover, a large portion of these costs can be attributed to in-patient management of exacerbations, including preventable ED visits and hospitalizations. 

The financial burden COPD places on our healthcare industry can be reduced or avoided by educating patients on how to manage their COPD properly. Wellinks takes a proactive, whole-person approach to COPD care to improve patient outcomes and reduce medical expenses.

  • 50% decrease in in-patient treatments
  • 40% decrease in emergency department visits
  • 15% decrease in other related medical expenses

Go Deeper: Show me the Numbers 

This approach is representative of the Value-Based Care (VBC) model and has the possibility to impact other diseases, thus lowering overall healthcare costs. While slowly being adopted across the healthcare industry, this model can significantly impact a disease like COPD as it is a progressive, non-curable disease with a history that demonstrates exacerbations create long-term deficits to a patient's health. Preventative care and avoiding exacerbations are techniques for managing this condition. However, it is essential to encourage self-efficacy and self-management for better patient results. PR is a vital piece in the puzzle for preventing the downward progression of those living with COPD, and the VBC model allows for more innovative approaches to disease management.

Go Deeper: AHIP Webinar 

Working Towards Change

It is clear that the current system for COPD care is not working. 

Individuals are not getting the care they need to manage their condition, and healthcare providers are overwhelmed and unable to meet the demand. The current approach to care is reactive, increasing costs on the individuals, providers, and payors. It's time for a change; "whole-person" care starts at the top. For patients, it's their quality of life which includes physical, mental, emotional, and financial health. For providers, it's their treatment plans' effectiveness and ability to give critical care where it's needed. For payors, it is the need to reduce costs wherever and whenever possible.

Wellinks is working to address significant gaps in COPD care. Contact us to learn how we can help improve outcomes and lower costs. 

Subscribe to our newsletter and follow us on social media to stay up to date on the latest industry news and updates.

*SOURCES:

American Lung Association - COPD Trends Brief: Prevalence 

National Library of Medicine - COPD Affects Worker Productivity and Health Care Costs

National Library of Medicine - The Need For Expanding Pulmonary Rehabilitation Services 

JAMA Network - Cost-Effectiveness of Pulmonary Rehabilitation Among US Adults with COPD

Driving Better Outcomes
COPD foundation logo and Wellinks logo - Wellinks Images

Wellinks is excited to announce the final results of ASPIRE – a clinical trial conducted with the COPD Foundation to assess the impact of Wellinks on quality of life, engagement and satisfaction among COPDF members living with COPD.

Circle with 3 images- laptop, smartphone and call screenshot - Wellinks Images
Each participant received personalized health coaching, virtual pulmonary rehabilitation, and monitoring through connected devices and a patient-facing app.

The study enrolled 141 members in the trial, with 119 completing the 24-week study. These results demonstrate sustained engagement, satisfaction, and clinical response with Wellinks.

Interested in learning more about Wellinks?

Request a Demo Today

Wellinks Engagement at 24 Weeks
(n = 141)

61%
Finger pressing the "Join" button - Wellinks Images
Enrollment Rate

Proportion successfully enrolled out of all who were interested and eligible

84%
Two hands shaking - Wellinks Images
Retention Rate

Proportion who remained enrolled in the study at 24 weeks

These results were demonstrated in a population with...

Web stats - Wellinks Images

High Member Satisfaction at 24 Weeks

  • Over 81% said Wellinks helped them better manage their COPD
  • Over 92% found Wellinks to be valuable
  • Over 83% said Wellinks helped them learn more about their COPD
+64
Net Promoter Score*
* Net Promoter Score (NPS) is a customer loyalty and satisfaction measurement taken from asking customers how likely they are to recommend your product. NPS scores range from -100 to +100. This NPS is based on responses from those who continued contact with coaches, representative of the Wellinks clinical model.

Improved Clinical Outcomes at 24 Weeks

Healthcare icon - Wellinks Images
Wellinks demonstrated sustained improvements in COPD self-efficacy as measured by the COPD Self-efficacy Scale (CSES) at 24 weeks.
Respiratory icon - Wellinks Images
Self-efficacy is a measure of how confident an individual is in managing their COPD and addressing shortness of breath.
Magnifying glass icon - Wellinks Images

One-third of participants demonstrated improvements in Modified Medical Research Council dyspnea score. mMRC is a measure of breathlessness that is associated with risk of future exacerbations.

Sign up to stay updated on ASPIRE and Wellinks.

Thank you! Stay tuned for more Wellinks news soon.

Oops! Something went wrong while submitting the form.
*By providing your email address, you agree to opt into receiving our Wellinks marketing emails.
You can unsubscribe at any time. Your information will be held confidential.